NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-203-2020-0-US-01 Star Co-polymers For Ligand Display And Small Molecule Drug Delivery US 62/835,268 Abandoned
NIA E-249-2016-0-MX-11 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO
THE CENTRAL NERVOUS SYSTEM 		MX National Stage MX/a/2019/004476 Issued
NCI E-238-2015-0-US-08 MOLECULAR NANOTAGS US National Stage 16/342,345 11536719 Issued PDF
NIDA E-077-2019-0-US-01 D3 RECEPTOR AGONIST COMPOUNDS; METHODS OF PREPARATION; INTERMEDIATES THEREOF; AND METHODS OF USE THEREOF US 62/833,023 Abandoned
CC E-184-2012-0-US-11 IMAGEABLE EMBOLIC MICROSPHERE US CON 16/381,204 Abandoned
NLM E-107-2010-2-US-28 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 16/380,846 11072818 Issued PDF
NCATS E-091-2016-0-US-07 COMPOUNDS AND METHOD FOR BLOCKING TRANSMISSION OF MALARIAL PARASITE US National Stage 16/341,000 10988472 Issued PDF
NCI E-065-2019-0-US-01 HYBRID NUCLEIC ACID SWITCHES US 62/832,171 Abandoned
NCI E-276-2016-0-US-05 HPPK INHIBITORS USEFUL AS ANTIBACTERIAL AGENTS US National Stage 16/340,493 11091509 Issued PDF
NCI E-113-2018-0-PCT-02 COMBINATION OF NEAR INFRARED PHOTOIMMUNOTHERAPY TARGETING CANCER CELLS AND HOST-IMMUNE ACTIVATION PCT PCT PCT/US2019/026488 Expired
NCI E-113-2018-0-CN-05 COMBINATION OF NEAR INFRARED PHOTOIMMUNOTHERAPY TARGETING CANCER CELLS AND HOST-IMMUNE ACTIVATION CN National Stage 201980039324.7 Abandoned
NCI E-113-2018-0-EP-06 COMBINATION OF NEAR INFRARED PHOTOIMMUNOTHERAPY TARGETING CANCER CELLS AND HOST-IMMUNE ACTIVATION EP National Stage 19723538.5 Abandoned
NCI E-113-2018-0-JP-07 COMBINATION OF NEAR INFRARED PHOTOIMMUNOTHERAPY TARGETING CANCER CELLS AND HOST-IMMUNE ACTIVATION JP National Stage 2020-555199 Abandoned
NCI E-113-2018-0-CA-04 COMBINATION OF NEAR INFRARED PHOTOIMMUNOTHERAPY TARGETING CANCER CELLS AND HOST-IMMUNE ACTIVATION CA National Stage 3096305 Abandoned
NIAID E-066-2020-0-US-01 Improvement Of Trispecific Antibodies To HIV-1 By Engraftment Of The FR3 Loop Of VRC03 (FR3-03) US 62/831,415 Abandoned
NCI E-113-2018-0-AU-03 COMBINATION OF NEAR INFRARED PHOTOIMMUNOTHERAPY TARGETING CANCER CELLS AND HOST-IMMUNE ACTIVATION AU National Stage 2019253681 Abandoned
NCI E-062-2019-3-AU-02 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide AU National Stage 2017336547 Abandoned
NCI E-062-2019-3-NZ-06 Method Of Treating Urothelial Carcinoma And Other Genitourinary Malignancies Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide NZ National Stage 752345 Abandoned
NCI E-271-2014-0-US-03 A New Class Of Stable Heptamethine Cyanine Fluorophores And Biomedical Applications Thereof US CON 16/374,642 10876003 Issued PDF
NCI E-173-2015-0-US-04 Module For Freezing And Storage Of Frozen Tissue US National Stage 16/338,860 11802821 Issued PDF
NIAID E-279-2016-1-US-03 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE US National Stage 16/338,964 11602559 Issued PDF
NCATS E-120-2018-0-US-01 Remodelins, A New Class Of Compounds To Prevent Airway Remodeling And To Prevent Fibrosis In Multiple Organs US 62/827,980 Abandoned
NCATS E-179-2018-0-US-01 Remodelins, A New Class Of Compounds To Prevent Or Treat Cancer Metastasis Or Glaucoma US 62/828,122 Abandoned
NHLBI E-078-2019-0-PCT-02 HELICAL GUIDEWIRES AND RELATED SYSTEMS PCT PCT PCT/US2019/025383 Expired
NIBIB E-225-2014-0-US-05 Resolution Enhancement With Line Scanning Excitation US CON 16/371,641 11106027 Issued PDF
NIAID E-228-2016-1-KR-10 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof KR National Stage 10-2019-7009334 Pending
NCI E-269-2010-0-ES-31 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE ES EP 19166061.2 Issued
NCI E-269-2010-0-PT-37 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE PT EP 19166061.2 Issued
NCI E-269-2010-0-BE-28 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE BE EP 19166061.2 Issued
NCI E-269-2010-0-AT-27 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE AT EP 19166061.2 Issued
NCI E-269-2010-0-IE-34 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE IE EP 19166061.2 Issued
NCI E-269-2010-0-IT-35 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE IT EP 19166061.2 Issued
NCI E-269-2010-0-NL-36 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE NL EP 19166061.2 Issued
NCI E-269-2010-0-GB-33 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE GB EP 19166061.2 Issued
NCI E-269-2010-0-CH-29 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE CH EP 19166061.2 Issued
NCI E-269-2010-0-EP-14 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE EP DIV 19166061.2 Issued
NCI E-269-2010-0-FR-32 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE FR EP 19166061.2 Issued
NCI E-269-2010-0-DE-30 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE DE EP 19166061.2 Issued
NCI E-105-2018-0-PCT-02 Biomarker Analysis Software For High-Throughput Diagnostic Multiplex Data PCT PCT PCT/US2019/024975 Expired
NCI E-062-2019-3-EP-04 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide EP National Stage 17791484.3 Abandoned
NIBIB E-005-2012-3-EP-09 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS EP National Stage 18814333.3 Pending
NCI E-105-2018-0-AU-03 Biomarker Analysis Software For High-Throughput Diagnostic Multiplex Data AU National Stage 2019245402 Pending
NCI E-105-2018-0-CA-04 Biomarker Analysis Software For High-Throughput Diagnostic Multiplex Data CA National Stage 3095485 Pending
NCI E-077-2017-0-US-02 CATIONIC LIPID VACCINE COMPOSITIONS AND METHODS OF USE US DIV 16/367,546 10828364 Issued PDF
NCATS E-252-2017-1-US-01 METHOD OF TREATMENT OF CANCER CELLS EXHIBITING TRAIL RESISTANCE US 68/825,397 Abandoned
NCATS E-091-2017-0-US-01 Mounted Nitrocellulose Membrane Plates For Aqueous Acoustic Dispensing Nanoliter-Scale Reverse Phase Protein And Biological Arrays For Antibody-Based Protein Detection And Quantification US 62/825,397 Abandoned
NIAID E-228-2016-1-AU-07 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof AU National Stage 2017321883 Issued
NIAID E-242-2011-0-US-06 Isolation Of Novel Broadly Neutralizing Monoclonal Antibodies Against HIV-1 Using Epitope-specific Glycoprotein Probes To Identify HIV-1 Specific B-cells US DIV 16/366,980 Abandoned
NHLBI E-207-2016-0-US-03 Method To Increase Carboxylic Acid Content On Fluorescent Nanodiamonds US National Stage 16/336,709 10995004 Issued PDF
NCI E-062-2019-3-JP-05 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide JP National Stage 2019-516536 Abandoned